3-N-苄基-戊酸 | 126946-59-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 3-N-苄基-戊酸
• 英文名称: 3-(benzylamino)pentanoic acid
• CAS: 126946-59-6
• 化学式: C₁₂H₁₇NO₂
• 分子量: 207.272
• InChiKey: KNSODENPZPJPQW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2922499990

反应信息

• 作为反应物：
  描述：

  3-N-苄基-戊酸 在 palladium dihydroxide 氢气 作用下， 以 甲醇 、 水 为溶剂， 70.0 ℃ 、9.0 MPa 条件下， 反应 24.0h， 以4.92 g的产率得到3-氨基戊酸
  参考文献：
  名称：

  Preparation of highly enantiopure β-amino esters by Candida antarctica lipase A

  摘要：

  The enantioselectivities for the reactions of aliphatic beta -substituted beta -amino esters [RCH(NH2)CH2CO2Et with R = Me, Et, n-Pr, i-Pr, CHEt2, cyclohexyl and Ph] with butyl butanoate in neat butyl butanoate and with 2,2,2-trifluoroethyl butanoate in diisopropyl ether were studied in the presence of Candida antarctica lipase A. Enantioselectivities ranging from good (E=70-100) to excellent (E>100) were commonly observed, allowing gram-scale resolution of the substrates. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(01)00002-7
• 作为产物：
  描述：

  反-2-戊酸甲酯 在 bismuth (III) nitrate pentahydrate 、 水 作用下， 反应 4.08h， 生成 3-N-苄基-戊酸
  参考文献：
  名称：

  N-苄基化-β3-氨基酯的机械化学酶促拆分。

  摘要：

  在过去的十年中，已经探索了使用机械化学进行对映选择性反应的研究，并取得了优异的成绩。几种手性有机催化剂甚至酶已被证明对研磨条件有抵抗力，这允许在球磨条件下相当有效的对映选择性转化。本文报道了利用南极假丝酵母脂肪酶B（CALB）进行外消旋β3-氨基酯的液体辅助研磨（LAG）机械化学酶促拆分的第一个实例，以高收率提供了高度有价值的对映体富集的N-苄基化β3-氨基酸。此外，本协议易于扩展。

  DOI：

  10.3762/bjoc.13.167

文献信息

• [EN] PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSÉS DE PYRIMIDINE, COMPOSITIONS ET PROCÉDÉS D'UTILISATION
  申请人：GENENTECH INC

  公开号：WO2010014939A1

  公开（公告）日：2010-02-04

  Disclosed are compounds of Formula I, including steroisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, that are useful in modulating PIKK related kinase signaling, e.g., mTOR, and for the treatment of diseases (e.g., cancer) that are mediated at least in part by the dysregulation of the PIKK signaling pathway (e.g., mTOR).

  揭示了公式I的化合物，包括立体异构体、几何异构体、互变异构体、溶剂合物、代谢物和其药学上可接受的盐，这些化合物在调节PIKK相关激酶信号传导方面很有用，例如mTOR，并用于治疗至少部分由PIKK信号传导途径失调引起的疾病（例如癌症）。
• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
  申请人：BORAGEN INC

  公开号：WO2021003501A1

  公开（公告）日：2021-01-07

  The present disclosure describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. Compounds of the disclosure have activity as dual modulators of Janus kinase (JAK), alone, or in combination with one or more of an additional mechanism, including a tyrosine kinase, such as TrkA or Syk, and PDE4, and are useful in the in the treatment or control of inflammation, auto-immune diseases, cancer, and other disorders and indications where modulation of JAK would be desirable. Also described herein are methods of treating inflammation, auto-immune diseases, cancer, and other conditions susceptible to inhibition of JAK and PDE4 by administering a compound herein described.

  本公开描述了新颖的化合物，或其药用可接受的盐，含有它们的药物组合物，以及它们的医疗用途。本公开的化合物具有作为Janus激酶（JAK）的双重调节剂的作用，单独使用，或与一个或多个附加机制（包括酪氨酸激酶，如TrkA或Syk，以及PDE4）结合使用，并且在治疗或控制炎症、自身免疫疾病、癌症以及其他调节JAK会可取的失调和其他适应症中是有用的。此外，还描述了通过施用本处所述的化合物来治疗炎症、自身免疫疾病、癌症以及其他易受JAK和PDE4抑制的状况的方法。
• Process for producing either optically active n-substituted beta-amino acid and optically active n-substituted beta-amino acid ester or optically active n-substituted 2-homopipecolic acid and optically active n-substituted 2-homopipecolic acid ester
  申请人：Miyata Hiroyuki

  公开号：US20050170473A1

  公开（公告）日：2005-08-04

  The present invention discloses a process which comprises selectively hydrolyzing one enantiomer of racemic mixtures of an N-substituted β-amino acid alkyl ester or N-substituted 2-homopipecolic acid ester represented by the formula (I): wherein Ar, R 1 , R 2 , R 3 , R 4 and R 5 are the same as defined in the specification, in the presence of a hydrolase to form an optically active ((R) or (S))-N-substituted-β-amino acid or optically active ((R) or (S))-N-substituted 2-homopipecolic acid represented by the formula (II): and simultaneously to obtain an unreacted optically active ((S) or (R))-N-substituted β-amino acid alkyl ester or unreacted optically active ((S) or (R))-N-substituted 2-homopipecolic acid ester represented by the formula (III): which has a reverse steric absolute configuration to that of the compound represented by the formula (II).

  本发明揭示了一种过程，该过程包括在水解酶的存在下，选择性水解由公式（I）表示的N-取代β-氨基酸烷基酯或N-取代2-同环丙氨酸酯的混合物的一个对映体，其中Ar，R1，R2，R3，R4和R5与说明书中定义的相同，形成一个光学活性的（R）或（S）-N-取代β-氨基酸或光学活性的（R）或（S）-N-取代2-同环丙氨酸，其由公式（II）表示，并同时获得未反应的光学活性的（S）或（R）-N-取代β-氨基酸烷基酯或未反应的光学活性的（S）或（R）-N-取代2-同环丙氨酸酯，其由公式（III）表示，其具有与由公式（II）表示的化合物相反的立体绝对构型。
• PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
  申请人：Bergeron Philippe

  公开号：US20100069357A1

  公开（公告）日：2010-03-18

  Disclosed are compounds of Formula I, including steroisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, that are useful in modulating PIKK related kinase signaling, e.g., mTOR, and for the treatment of diseases (e.g., cancer) that are mediated at least in part by the dysregulation of the PIKK signaling pathway (e.g., mTOR).

  本发明涉及I式化合物，包括其立体异构体、几何异构体、互变异构体、溶剂化物、代谢物和药学上可接受的盐，其对调节PIKK相关激酶信号传导，例如mTOR，并用于治疗至少部分由PIKK信号通路失调介导的疾病（例如癌症）具有用处。
• PROCESS FOR PRODUCING EITHER OPTICALLY ACTIVE N-SUBSTITUTED BETA-AMINO ACID AND OPTICALLY ACTIVE N-SUBSTITUTED BETA-AMINO ACID ESTER OR OPTICALLY ACTIVE N-SUBSTITUTED 2-HOMOPIPECOLIC ACID AND OPTICALLY ACTIVE N-SUBSTITUTED 2-HOMOPIPECOLIC ACID ESTER
  申请人：Ube Industries, Ltd.

  公开号：EP1493819A1

  公开（公告）日：2005-01-05

  The present invention discloses a process which comprises selectively hydrolyzing one enantiomer of racemic mixtures of an N-substituted β-amino acid alkyl ester or N-substituted 2-homopipecolic acid ester represented by the formula (I):    wherein Ar, R1, R2, R3, R4 and R5 are the same as defined in the specification, in the presence of a hydrolase to form an optically active ((R) or (S))-N-substituted β-amino acid or optically active ((R) or (S))-N-substituted 2-homopipecolic acid represented by the formula (II): and simultaneously to obtain an unreacted optically active ((S) or (R))-N-substituted β-amino acid alkyl ester or unreacted optically active ((S) or (R))-N-substituted 2-homopipecolic acid ester represented by the formula (III): which has a reverse steric absolute configuration to that of the compound represented by the formula (II).

  本发明公开了一种工艺，该工艺包括选择性地水解由式（I）代表的 N-取代β-氨基酸烷基酯或 N-取代 2-高哌啶酸酯的外消旋混合物中的一种对映体： 其中 Ar、R1、R2、R3、R4 和 R5 与说明书中定义的相同、 在水解酶存在下，生成光学活性（(R)或(S)）-N-取代的 β-氨基酸或光学活性（(R)或(S)）-N-取代的由式（II）代表的 2-高代联哌醇酸： 并同时得到未反应的具有光学活性的((S)或(R))-N-取代的 β-氨基酸烷基酯或未反应的具有光学活性的((S)或(R))-N-取代的 2-高代联哌羧酸酯，由式(III)代表： 其立体绝对构型与式 (II) 所代表化合物的立体绝对构型相反。